Cargando…

COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?

Detalles Bibliográficos
Autores principales:	Aubignat, M., Godefroy, O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205702/ https://www.ncbi.nlm.nih.gov/pubmed/32409176 http://dx.doi.org/10.1016/j.neurol.2020.05.001

Ejemplares similares

Indication and outcome of lupus anticoagulant and antiphospholipid antibodies testing in routine clinical practice
por: Kempers, Eva K, et al.
Publicado: (2021)

Ischemic Stroke From Libman-Sacks Endocarditis Not Associated With Antiphospholipid Antibodies: Good Clinical Outcome Without Anticoagulation
por: Krawczyk, Michal, et al.
Publicado: (2019)

Antiphospholipid Antibodies in Lupus Nephritis
por: Parodis, Ioannis, et al.
Publicado: (2016)

Antiphospholipid Syndrome Secondary to Lupus Anticoagulant: Case Report for Clinical Anticoagulation Determination
por: Lambroussis, Constantino G, et al.
Publicado: (2022)

Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings
por: Ferrari, Giorgia, et al.
Publicado: (2021)

IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022)

Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity
por: Pyo, Jung Yoon, et al.
Publicado: (2017)

The impact of antiphospholipid antibodies in children with lupus nephritis
por: Al-Mayouf, Sulaiman M., et al.
Publicado: (2015)

Acute Ischemic Stroke in Children – Should We Thrombolyze?
por: Vinayan, K. P., et al.
Publicado: (2022)

Case Report: Infantile Ischemic Stroke and Antiphospholipid Antibodies, Description of Four Cases
por: Giani, Teresa, et al.
Publicado: (2020)

Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
por: Naranjo, Laura, et al.
Publicado: (2021)

Lupus mastitis and antiphospholipid syndrome treated with anticoagulation and immunosuppression: a case report
por: He, Lauren J., et al.
Publicado: (2023)

Ischemic colitis due to antiphospholipid antibody syndrome
por: Choobi Anzali, Babak, et al.
Publicado: (2018)

Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
por: Huang, Can, et al.
Publicado: (2022)

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
por: Sciascia, Savino, et al.
Publicado: (2019)

Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome
por: Okuma, Hirohisa, et al.
Publicado: (2009)

Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
por: Capecchi, Marco, et al.
Publicado: (2022)

Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome
por: Hanaoka, Hironari, et al.
Publicado: (2018)

Antiphospholipid syndrome in lupus retinopathy
por: Hong-Kee, Ng, et al.
Publicado: (2014)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

Severe asthma and allergy - should we look for the allergens
por: Lazova, Snezhina, et al.
Publicado: (2015)

Tics and Shorter Stature: Should We Be Looking for an Association?
por: Holleb, Peter, et al.
Publicado: (2014)

Thoughts From the Trenches: Should We Look at the “Healthy”?
por: Martínez-Taboada, Víctor M., et al.
Publicado: (2020)

Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus
por: Petrovic, Gordana, et al.
Publicado: (2023)

An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
por: Hisada, Ryo, et al.
Publicado: (2023)

Should we treat sepsis-induced DIC with anticoagulants?
por: Inata, Yu
Publicado: (2020)

Antiphospholipid antibodies and COVID-19
por: La Cava, Antonio
Publicado: (2021)

COVID-19 and antiphospholipid antibodies
por: Butt, Ayesha, et al.
Publicado: (2022)

Catastrophic Antiphospholipid Syndrome Presenting as a Stroke in an 11-Year-Old with Lupus
por: Senken, Brooke, et al.
Publicado: (2022)

Relationship between osteonecrosis and antiphospholipid antibodies in patients with systemic lupus erythematosus: a systematic review protocol
por: Wei, Qijiao, et al.
Publicado: (2021)

Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients
por: Tripodi, Armando, et al.
Publicado: (2023)

Ischemic Stroke in a Young Patient with Nephrotic Syndrome and Antiphospholipid Syndrome
por: Neoh, K. K., et al.
Publicado: (2020)

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
por: Monzón Manzano, Elena, et al.
Publicado: (2020)

Why We Should Take a Closer Look at Gestures
por: Walther, Sebastian, et al.
Publicado: (2016)

Anticoagulation for the Acute Management of Ischemic Stroke
por: Robinson, Austin A., et al.
Publicado: (2014)

Anticoagulants for cancer-associated ischemic stroke
por: Hsu, Jin-Yi, et al.
Publicado: (2019)

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019)

Should we test the prothrombin time in anticoagulated epistaxis patients?
por: Soyka, Michael B., et al.
Publicado: (2013)

Cerebrovascular Accident due to Thyroid Storm: Should We Anticoagulate?
por: Gonzalez-Bossolo, Alex, et al.
Publicado: (2016)

Cervical carotid occlusion in acute ischemic stroke: Should we give tPA?
por: Elder, Theresa A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l6h0nru1o5ftummji26cq6moco